Clinical trial · Interventional
The Effect of Yogurt in Cancer Patient With Moderate Gastrointestinal (GI) Symptoms
NCT03177681CI-TRIAL-00065030withdrawnN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): 0 patient accrual
Summary
Brief summary (as posted)
The goal of this clinical research study is to learn if probiotics found in yogurt can help to decrease gastrointestinal (GI) symptoms in cancer patients. Probiotics are live bacteria and yeast that help with many of our functions and may help digestive problems. Researchers also want to learn if the bacteria in your stool change as your symptoms change while eating yogurt.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Malignant Neoplasms of Independent (Primary) Multiple Sites | — | UNRESOLVED | — |
Interventions
Interventions (5)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Holter Monitor | Device | — | UNRESOLVED |
| Questionnaires | Behavioral | — | UNRESOLVED |
| Stool Sample | Other | — | UNRESOLVED |
| Tongue Assessment | Other | — | UNRESOLVED |
| Yogurt | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Group 1 - Antibiotics Taken During Past 2 Weeks
- description
- Group 1: Participant was on antibiotics anytime during the past 2 weeks prior to the time of enrollment. Tongue assessment, stool sample, and questionnaires done at baseline and once during Days 3-7 and once during Days 8-12. Participants wear a Holter monitor for 20-24 hours at baseline and once during Days 3-7 and once during Days 8-12. Participants given 2 tablespoons (33 cc) of yogurt each day for 12 days.
- interventionNames
- Other: Tongue Assessment
- Other: Stool Sample
- Behavioral: Questionnaires
- Device: Holter Monitor
- Other: Yogurt
- type
- EXPERIMENTAL
- label
- Group 2 - No Antibiotics Taken During Past 2 Weeks
- description
- Group 2: Participant has not been on antibiotics in the past 2 weeks. Tongue assessment, stool sample, and questionnaires done at baseline and once during Days 3-7 and once during Days 8-12. Participants wear a Holter monitor for 20-24 hours at baseline and once during Days 3-7 and once during Days 8-12. Participants given 2 tablespoons (33 cc) of yogurt each day for 12 days.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. Cancer patient 2. 18 years old or older 3. Has gastrointestinal symptoms with severity score of \</= 60 out of 100 visual analog scale for irritable bowel syndrome (VAS-IBS) in at least 2 out of 7 items measured 4. Able to eat by mouth 5. Estimated length of hospital stay is 10 days or more 6. Must give written study consent Exclusion Criteria: 1. Neutropenic patient with absolute neutrophil count (ANC) less than 1000 cells/mm3 2. Patient within 100 days of auto /allo stem cell transplant and their stem cell physician does not approve yogurt ingestion. 3. Has intestinal obstruction. 4. Patient is currently on antibiotics 5. Allergic to yogurt 6. Patient who eats yogurt equal or more than once a day in the last 3 days.
References
Publications (0)
Data not yet available
No reference posted for this study.